Copyright: ©Author(s) 2026.
World J Gastroenterol. Oct 7, 2026; 32(37): 120885
Published online Oct 7, 2026. doi: 10.3748/wjg.120885
Published online Oct 7, 2026. doi: 10.3748/wjg.120885
Figure 5 Portulaca oleracea L.
-derived exosome-like nanoparticles regulate gut metabolites in dextran sulfate sodium-induced colitis mice. A: Principal component analysis; B: Partial least squares-discriminant analysis; C: Volcano plot of differential metabolites; D: Bubble chart of KEGG pathway enrichment analysis for differential metabolite sets in mouse gut; E: Correlation analysis between gut microbiota and ulcerative colitis (UC)-related indicators; F: Correlation analysis between metabolites and UC-related indicators; G: Correlation analysis between gut microbiota and metabolites. aP < 0.05, bP < 0.01, cP < 0.001. DSS: Dextran sulfate sodium; PELNs: Portulaca oleracea L.-derived exosome-like nanoparticles; 5-ASA: 5-aminosalicylic acid; PCA: Principal component analysis; PLS-DA: Partial least squares-discriminant analysis.
- Citation: Liu XY, Liu ZX, Tan WW, Zhang WB, Qiao D, Chen SH, Zhang YL, Zheng L, Ge WS, Dai YC. Portulaca oleracea L.-derived exosome-like nanoparticles ameliorate colitis by modulating gut microbiota and metabolites to reduce endoplasmic reticulum stress. World J Gastroenterol 2026; 32(37): 120885
- URL: https://www.wjgnet.com/1007-9327/full/v32/i37/120885.htm
- DOI: https://dx.doi.org/10.3748/wjg.120885